Sickle Cell Anemia and Severe Infections Due to Encapsulated Bacteria
about
Conjugate Haemophilus influenzae type b vaccines for sickle cell diseaseConjugate Haemophilus influenzae type b vaccines for sickle cell diseaseDuration of penicillin prophylaxis in sickle cell anemia: issues and controversies.Adverse Reactions to Pneumococcal Vaccine in Pediatric and Adolescent Patients with Sickle Cell Disease.Sickle cell disease in the Sudan. Clinical and biochemical aspects. Minireview based on a doctoral thesis.Oxidative stress in sickle cell disease; pathophysiology and potential implications for disease management.Improving outcomes in children with sickle cell disease: treatment considerations and strategies.Splenic enlargement in adults with homozygous sickle cell disease: the Jamaican experience.Prevalence of pneumococcal polysaccharide vaccine administration and incidence of invasive pneumococcal disease in children in Jamaica aged over 4 years with sickle cell disease diagnosed by newborn screening.Outpatient management of fever in children with sickle cell disease (SCD) in an African setting.Pattern of bacteraemia in febrile children with sickle cell anaemia.13-valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6-17 years of age with sickle cell disease previously vaccinated with 23-valent pneumococcal polysaccharide vaccine (PPSV23): Results of a phase 3 study.Lack of evidence for altered complement and immunoglobulin levels in patients with sickle cell anaemia.Durable immune response to inactivated H1N1 vaccine is less likely in children with sickle cell anemia receiving chronic transfusions.Lymphocyte blastogenic responses in sickle cell disease.Neonatal screening for sickle cell disease in a metropolitan university hospital: efficacy and problems.Spleen in sickle cell anemia: comparative studies of Nigerian and U.S. patients.Using Brownian motion to measure shape asymmetry in mesoscopic matter using optical tweezers.
P2860
Q24186131-36C43D63-AD66-4E4E-B064-F88AD07FCB86Q24195046-37F3E06A-3DFD-4C0E-A57B-D98A97BABA15Q33821324-22B8B5DE-64A5-4910-8BB2-5EB3C0392FB7Q33922182-6EE7CA39-06DD-4AAE-827B-C947A60832C8Q35221368-1C59A18D-4885-46AA-8AB5-E8867BF1C03CQ37872265-2F6BDA96-3199-4C27-92C8-4BB00E4C2933Q38209472-A34FAE7F-F283-4C0E-AA73-DE89E5FB9869Q38882070-C5C06C6C-27AA-4432-9F3A-E049F62A7F81Q39046588-1608E1C7-D832-484B-B2B7-4D490ACC8EADQ40633709-D5652011-A7BE-4BB0-93E3-5A8831B75692Q40725524-B0E9676D-9FE1-4C99-9761-D871A86A3F1DQ41382795-16EF62EB-015C-4750-91F8-39230DAA683FQ43840072-6884C702-2A6B-4AE6-A4F2-39B4CFFC3E70Q44302778-AD323DE4-4790-4703-ACAB-926EAE6C57AEQ46454934-6A17FB66-1857-4524-B4C8-53D26CB55A79Q46880408-C636CB28-3838-431E-B3AB-83B7A9251214Q48022235-C6533577-68F2-4CB1-9E5B-A9D7D9EC19D4Q50239629-77C60A7D-912A-448B-A544-1519DC63C435
P2860
Sickle Cell Anemia and Severe Infections Due to Encapsulated Bacteria
description
1977 nî lūn-bûn
@nan
1977 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1977 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1977年の論文
@ja
1977年論文
@yue
1977年論文
@zh-hant
1977年論文
@zh-hk
1977年論文
@zh-mo
1977年論文
@zh-tw
1977年论文
@wuu
name
Sickle Cell Anemia and Severe Infections Due to Encapsulated Bacteria
@ast
Sickle Cell Anemia and Severe Infections Due to Encapsulated Bacteria
@en
type
label
Sickle Cell Anemia and Severe Infections Due to Encapsulated Bacteria
@ast
Sickle Cell Anemia and Severe Infections Due to Encapsulated Bacteria
@en
prefLabel
Sickle Cell Anemia and Severe Infections Due to Encapsulated Bacteria
@ast
Sickle Cell Anemia and Severe Infections Due to Encapsulated Bacteria
@en
P1476
Sickle Cell Anemia and Severe Infections Due to Encapsulated Bacteria
@en
P2093
H. A. Pearson
P304
P356
10.1093/INFDIS/136.SUPPLEMENT.S25
P407
P433
Supplement 1
P577
1977-08-01T00:00:00Z